Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation

Rong-Li ZHANG; Xiao-Hui ZHENG; Lu-Kun ZHOU; Ying ZHANG; Shu-Lian CHEN; Dong-Lin YANG; Er-Lie JIANG; Jia-Lin WEI; Yong HUANG; Qiao-Ling MA; Wei-Hua ZHAI; Si-Zhou FENG; Ming-Zhe HAN; Yi HE.
Chinese Journal of Hematology ; (12): 190-195, 2018.
Artículo en Zh | WPRIM | ID: wpr-1011723

Documentos relacionados

  1. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
  2. Outcomes of patients who underwent treatment for anti-HLA donor-specific antibodies before receiving a haploidentical hematopoietic cell transplant.
  3. Fludarabine-based Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in a Pediatric Patient With Bone Marrow Failure Syndrome Type 3.
  4. HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.
  5. Hematopoietic Stem Cell Transplantation for Shwachman-Diamond Syndrome.
  6. [Effect of sirolimus combined with anti-CD20 monoclonal antibody desensitization on the prognosis of patients underwent haploidentical stem cell transplantation].
  7. Current Concepts and Advances in Graft-Versus-Host Disease Immunology.
  8. The challenges presented by haematopoietic stem cell transplantation in children with primary immunodeficiency.
  9. TCRαß/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.
  10. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.